Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Atg8 transfer from Atg7 to Atg3: a distinctive E1-E2 architecture and mechanism in the autophagy pathway.

Molecular cell | 2011

Atg7 is a noncanonical, homodimeric E1 enzyme that interacts with the noncanonical E2 enzyme, Atg3, to mediate conjugation of the ubiquitin-like protein (UBL) Atg8 during autophagy. Here we report that the unique N-terminal domain of Atg7 (Atg7(NTD)) recruits a unique "flexible region" from Atg3 (Atg3(FR)). The structure of an Atg7(NTD)-Atg3(FR) complex reveals hydrophobic residues from Atg3 engaging a conserved groove in Atg7, important for Atg8 conjugation. We also report the structure of the homodimeric Atg7 C-terminal domain, which is homologous to canonical E1s and bacterial antecedents. The structures, SAXS, and crosslinking data allow modeling of a full-length, dimeric (Atg7~Atg8-Atg3)(2) complex. The model and biochemical data provide a rationale for Atg7 dimerization: Atg8 is transferred in trans from the catalytic cysteine of one Atg7 protomer to Atg3 bound to the N-terminal domain of the opposite Atg7 protomer within the homodimer. The studies reveal a distinctive E1~UBL-E2 architecture for enzymes mediating autophagy.

Pubmed ID: 22055190 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: R01 AI040646-10
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM077053-03
  • Agency: NCRR NIH HHS, United States
    Id: P41 RR015301
  • Agency: NIGMS NIH HHS, United States
    Id: R37 GM034496-25
  • Agency: NIGMS NIH HHS, United States
    Id: R01GM034496
  • Agency: NCRR NIH HHS, United States
    Id: RR-15301
  • Agency: NIAID NIH HHS, United States
    Id: R01AI40646
  • Agency: NIGMS NIH HHS, United States
    Id: R37 GM034496-26
  • Agency: NCI NIH HHS, United States
    Id: P30 CA021765-31
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM077053
  • Agency: NCI NIH HHS, United States
    Id: P30 CA021765-33
  • Agency: NIGMS NIH HHS, United States
    Id: R01GM077053
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM077053-05
  • Agency: NCI NIH HHS, United States
    Id: P30 CA021765-32
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM077053-04
  • Agency: NCI NIH HHS, United States
    Id: P30 CA021765
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM034496
  • Agency: NIGMS NIH HHS, United States
    Id: R37 GM034496-24
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI040646-09
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI040646-08
  • Agency: NIGMS NIH HHS, United States
    Id: R37 GM034496
  • Agency: NCI NIH HHS, United States
    Id: NIH5P30CA021765
  • Agency: Howard Hughes Medical Institute, United States
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI040646

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


New England Biolabs (tool)

RRID:SCR_013517

An Antibody supplier

View all literature mentions